Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 83,320 shares at $222.83 ($18.6M) on 2025-05-13, disclosed to the SEC on 2025-05-15.
Scheduled sale ($18.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $222.83 | 10,221 | $2.3M | 12.2% |
| 2 | $222.83 | 10,221 | $2.3M | 12.2% |
| 3 | $223.41 | 21,235 | $4.7M | 25.5% |
| 4 | $223.41 | 21,235 | $4.7M | 25.5% |
| 5 | $224.32 | 10,104 | $2.3M | 12.2% |
| 6 | $224.32 | 10,104 |
| $2.3M |
| 12.2% |
| 7 | $225.68 | 200 | $45K | 0.2% |
| Total | $223.49 avg | 83,320 | $18.6M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-04-16 | $20.3M | — | Filing → |